Back to Search
DAVID SCHRUMP, MD, MBA
MD, MBA
Specialist
NPI: 1720374226Individual
Specialties, Licenses & Credentials
SpecialistPrimary
Specialist
Code: 174400000X
J5010(TX)
Research & Publications (20)
Cytotoxicity mediated by histone deacetylase inhibitors in cancer cells: mechanisms and potential clinical implications.
PMID 19509170·Clin Cancer Res·2009
6-review
Clinical and molecular responses in lung cancer patients receiving Romidepsin.
PMID 18172270·Clin Cancer Res·2008
3-trial
Targeting the epigenome for the treatment of thoracic malignancies.
PMID 17240824·Thorac Surg Clin·2006
6-review
Phase I study of decitabine-mediated gene expression in patients with cancers involving the lungs, esophagus, or pleura.
PMID 17020984·Clin Cancer Res·2006
3-trial
Targeting the epigenome for the treatment and prevention of lung cancer.
PMID 16210090·Semin Oncol·2005
6-review
Pharmacokinetics of paclitaxel administered by hyperthermic retrograde isolated lung perfusion techniques.
PMID 11986596·J Thorac Cardiovasc Surg·2002
4-observational
Phase I study of sequential deoxyazacytidine/depsipeptide infusion in patients with malignancies involving lungs or pleura.
PMID 14706169·Clin Lung Cancer·2002
8-other
Targets for molecular intervention in multistep pulmonary carcinogenesis.
PMID 11338019·World J Surg·2001
6-review
Strategies to circumvent SV40 oncoprotein expression in malignant pleural mesotheliomas.
PMID 11243901·Semin Cancer Biol·2001
6-review
Tobacco smoke induces polycomb-mediated repression of Dickkopf-1 in lung cancer cells.
PMID 19351856·Cancer Res·2009
7-preclinical
Therapeutic vulnerability of an in vivo model of alveolar soft part sarcoma (ASPS) to antiangiogenic therapy.
PMID 19636271·J Pediatr Hematol Oncol·2009
7-preclinical
Gene expression profiling of alveolar soft-part sarcoma (ASPS).
PMID 19146682·BMC Cancer·2009
4-observational
Recognition of NY-ESO-1+ tumor cells by engineered lymphocytes is enhanced by improved vector design and epigenetic modulation of tumor antigen expression.
PMID 18677478·Cancer Immunol Immunother·2009
8-other
Cisplatin enhances the antitumor effect of tumor necrosis factor-related apoptosis-inducing ligand gene therapy via recruitment of the mitochondria-dependent death signaling pathway.
PMID 18309355·Cancer Gene Ther·2008
7-preclinical
Aurora A, Aurora B and survivin are novel targets of transcriptional regulation by histone deacetylase inhibitors in non-small cell lung cancer.
PMID 18708766·Cancer Biol Ther·2008
8-other
Global expression analysis of cancer/testis genes in uterine cancers reveals a high incidence of BORIS expression.
PMID 17363524·Clin Cancer Res·2007
8-other
The workup of stridor: virtual bronchoscopy as a complementary technique in the diagnosis of subglottic stenosis.
PMID 17375441·Respir Care·2007
5-case
The essential role of the mitochondria and reactive oxygen species in Cisplatin-mediated enhancement of fas ligand-induced apoptosis in malignant pleural mesothelioma.
PMID 17574045·J Surg Res·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- RM 4 3942 BLDG 10, 10 CENTER DRIVE
BETHESDA, MD 20892 - Phone
- (301) 496-2128
Quick Facts
- NPI
- 1720374226
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile